Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1), two immune checkpoints that control lymphocyte activation and balance immune responses, can shield tumor cells from the immune system [16]. This evidence concerns the gene PDCD1 and neoplasm.